Why GLP-1 Medications Are Suddenly Everywhere And what That Means for People With EDS, MCAS, and POTS GLP-1 medications have moved rapidly from medical journals into mainstream conversation
Synthetic cyclic -MSH analogue, 99% purity, COA on request
Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery SystemsA Literature Review
Within the first few weeks, many patients notice reduced appetite, fewer cravings, and improved portion control after starting Semaglutide, Tirzepatide, or Retatrutide treatment
Here's how it helps: After eating, tirzepatide triggers the pancreas to release more insulin, helping the body process glucose more efficiently